Drug Database
Back to search

Netherlands· NL-a766d175a941

NiQuitin Clear 14 mg/24 uur, pleister voor transdermaal gebruik

A nicotine product containing nicotine, registered in Netherlands by Omega Pharma Nederland B.V.. The same ATC class is registered in 15 of our 19 countries.

ATC N07BA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedNiQuitin Clear 14 mg/24 uur, pleister…ATCN07BA01REGISTER NO.NL-a766d175a941PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nicotineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nicotine is registered in 15 of 19 countries.

Countries holding a registration under ATC N07BA01 (nicotine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search nicotine products by name

Nicotine · ATC N07BA01

15 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nicotine costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $4.40 in France to $6.98 in United States — a ×1.6 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Nicotine · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • US United States$6.98 (acquisition cost)
  • FR France$4.40
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
NICOTINE
Manufacturer
Omega Pharma Nederland B.V.
Country
Netherlands (NL)
ATC code
N07BA01
ATC class
Nicotine
Defined daily dose
60 mg, Inhalation
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    28274

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

129 interactions on record for nicotine.

Graded by severity as the source publishes them — 6 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nicotine against other medicinesHow interaction checks work

Nicotine · interactions on record

129 records

  • 6 moderate
  • 5 minor
  • 118 info

Most severe, free to view

  • CeritinibL01ED02moderate
  • AlpelisibL01EM03moderate
  • CeritinibL01XE28moderate
  • AlpelisibL01XX65moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fb4d004e-eabe-418d-ae0b-5a9cd5b1fa8b
GET /v1/drugs/fb4d004e-eabe-418d-ae0b-5a9cd5b1fa8b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Pleister voor transdermaal gebruik",
  "route": "Transdermaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h28274_smpc.pdf",
  "strength": null,
  "atc_label": "Nicotine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg28274",
  "excipients": [
    "COPOLYMEER VAN ETHYLEEN-VINYLACETAAT (40 pCt. vinylacetaat)",
    "POLYESTERFILM, GESILICONEERD",
    "POLYETHYLEEN",
    "POLYETHYLEENTEREPHTHALAAT-ETHYLVINYLACETAAT FILM",
    "POLYISOBUTEEN",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "NICOTINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h28274.pdf",
  "authorised_at": "2010/07/19",
  "procedure_number": "SE/H/0300/005",
  "dispensing_status": "Algemene verkoop [conform voorwaarden CBG AV-lijst d.d. 1 mei 2014]",
  "registration_number": "28274",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about nicotine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console